Safety and efficacy of monoclonal antibodies for Alzheimer’s disease: a systematic review and meta-analysis of published and unpublished clinical trials

Manuscript Number: 

22-0046R1

Author(s): 
Antonio Ancidoni, Ilaria Bacigalupo, Guido Bellomo, Marco Canevelli, Massimo Corbo, Eleonora Lacorte, Flavia L. Lombardo, Paola Piscopo, Giulia Remoli, Francesco Sciancalepore, Leonardo Tariciotti, Nicola Vanacore, Valerio Zaccaria

Disclosures

Antonio Ancidoni

  • Nothing to Disclose

Ilaria Bacigalupo

  • Nothing to Disclose

Guido Bellomo

  • Nothing to Disclose

Marco Canevelli

  • Nothing to Disclose

Massimo Corbo

  • Consulting Fees:
    Consulting for Biogen Inc. (collaboration in the drafting of educational texts on Alzheimer's disease).

Eleonora Lacorte

  • Nothing to Disclose

Flavia L. Lombardo

  • Nothing to Disclose

Paola Piscopo

  • Nothing to Disclose

Giulia Remoli

  • Nothing to Disclose

Francesco Sciancalepore

  • Nothing to Disclose

Leonardo Tariciotti

  • Nothing to Disclose

Nicola Vanacore

  • Nothing to Disclose

Valerio Zaccaria

  • Nothing to Disclose